Varicella (Chickenpox)
The acute viral exanthem that classically presents with a pruritic rash starting on the trunk and spreading to the extremities is varicella (chickenpox), caused by varicella-zoster virus (VZV). 1, 2, 3
Clinical Presentation
Varicella presents with a characteristic pattern that distinguishes it from other viral exanthems:
- Incubation period: 14-16 days (range: 10-21 days) after exposure 2, 3
- Prodrome: Fever and malaise typically precede or accompany the rash
- Rash distribution: The eruption is more concentrated on the trunk and head than on the extremities 3—this centripetal (trunk-to-extremity) pattern is pathognomonic
- Rash characteristics:
- Begins as erythematous macules that rapidly progress through papules → vesicles → pustules → crusted lesions
- Lesions appear in successive "crops" over 4-6 days, resulting in lesions in varying stages of development simultaneously 1, 2
- Typically 250-500 lesions in unvaccinated children 3
- Intensely pruritic 1
- Vesicles are described as "dewdrops on a rose petal"
Key Distinguishing Features
The combination of pruritic rash + trunk-predominant distribution + lesions in multiple stages is virtually diagnostic of varicella. This differs from:
- Roseola infantum (HHV-6/7): Rash appears after fever resolves (not during), starts on trunk but is typically non-pruritic or mildly pruritic, and consists of uniform rose-pink macules 4
- Parvovirus B19: Usually causes "slapped cheek" appearance or reticular pattern on extremities, though atypical presentations exist 5, 6
- Rocky Mountain Spotted Fever: Rash begins on wrists/ankles and spreads centripetally (opposite direction) 7
Contagiousness and Isolation
Patients are contagious from 1-2 days before rash onset until all lesions are crusted (typically 4-7 days after rash appears) 2. This has critical implications for infection control in healthcare and school settings.
Management Approach
For immunocompetent children: Treatment is supportive with antipyretics and antipruritic measures. Oral antihistamines and topical calamine lotion can reduce itching 3.
For immunocompromised patients or severe disease: High-dose IV acyclovir is the treatment of choice 8, 9. Oral acyclovir, famciclovir, or valacyclovir may be used for mild cases or to complete therapy after clinical response to IV treatment 8.
Critical Pitfall
Breakthrough varicella in vaccinated individuals presents atypically with <50 lesions, predominantly maculopapular (rather than vesicular) rash, minimal fever, and shorter duration 2. Despite the milder presentation, these cases remain contagious and should be isolated appropriately. The trunk-to-extremity distribution pattern typically persists even in breakthrough cases.